The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions

References

• Organisation for Economic Co-operation and Development (OECD). Measuring expenditure on health-related R&D. 2001; Paris: OECD.
   Google Scholar
• Organisation for Economic Co-operation and Development (OECD). Frascati manual: proposed standard practice for surveys on research and experimental development. 2002; Paris: Organisation for Economic Co-operation and Development (OECD). 6th edition.
   Google Scholar
• G-FINDER. R&D scope document. Available from: http://g-finder.policycures.org/g-finder/registered/docs/help.jsp#OUT OF SCOPE (Excluded from the survey) [cited 2 October 2013]..
   Google Scholar
• Commission on Health Research for Development. Health research: essential link to equity in development. 1990; New York: Oxford University Press. 157. Available from: http://www.cohred.org/downloads/open_archive/ComReports_0.pdf [cited 2 October 2013]..
   Google Scholar
• Murray CJL , Vos T , Lozano R , Naghavi M , Flaxman AD , Michaud C . Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2197–223.
   Google Scholar
• Røttingen J-A , Regmi S , Eide M , Young AJ , Viergever RF , Årdal C . Mapping available health R&D data: what's there, what's missing and what role for a Global Observatory. Lancet. 2013. Epub ahead of print, 17 May 2013.
   Google Scholar
• The Consultative Expert Working Group on Research and Development: Financing and Coordination (2012). Research and development to meet health needs in developing countries: strengthening global financing and coordination. Geneva. Available from: http://www.who.int/phi/cewg_report/en/index.html [cited 2 October 2013]..
   Google Scholar
• Fleck F . Spending on neglected diseases has increased, says report. BMJ. 2004; 328: 1220.
   Google Scholar
• Global Forum for Health Research. The 10/90 report on health research 2003–2004. 2004; Geneva: Global Forum for Health Research.
   Google Scholar
• Moon S , Bermudez J , 't Hoen E . Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?. PLoS Med. 2012; 9 e1001218.
   Web of Science ®Google Scholar
• Moran M , Guzman J , Ropars A-L , McDonald A , Sturm T , Jameson N . G-FINDER 2008 – neglected disease research & development: how much are we really spending? Sydney. 2009. Available from: http://www.policycures.org/downloads/G-FINDER_survey_of_global_R&D_funding_for_Neglected_diseases_2008.pdf [cited 2 October 2013]..
   Google Scholar
• Moran M , Guzman J , Henderson K , Liyanage R , Wu L , Chin E . G-FINDER 2012 – neglected disease research & development: a five year review. 2012; Policy Cures: Sydney.
   Google Scholar
• Power E . Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect. 2006; 12: 25–34.
   Google Scholar
• Viergever RF , Rademaker CMA , Ghersi D . Pharmacokinetic research in children: an analysis of registered records of clinical trials. BMJ Open. 2011; 1: e000221.
   Google Scholar
• Institute of Medicine (US) Committee on Clinical Research Involving Children. Field M , Behrman R . The necessity and challenges of clinical research involving children. Ethical conduct of clinical research involving children. 2004; Washington, DC: National Academies Press. Available from: http://www.ncbi.nlm.nih.gov/books/NBK25553/#a2000a7b4ddd00042 [cited 2 October 2013]..
   Google Scholar
• Herder M . When everyone is an orphan: against adopting a U.S.-styled orphan drug policy in Canada. Account Res. 2013; 20: 227–69.
   Google Scholar
• Love J . WHO∣balancing options for health research and development. Bull World Health Organ. 2012; 90 796–796A.
   Web of Science ®Google Scholar
• Moran M . Debating the scope of a health research and development convention. Bull World Health Organ. 2013; 91: 618–620.
   Google Scholar
• Viergever RF , Terry RF , Karam G . Use of data from registered clinical trials to identify gaps in health research and development. Bull World Health Organ. 2013; 91: 416–25C.
   Google Scholar
• Shiffman J . Donor funding priorities for communicable disease control in the developing world. Health Policy Plan. 2006; 21: 411–20.
   Google Scholar
• What has the Gates Foundation done for global health?. Lancet. 2009; 373: 1577.
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez E , Zaragoza ML , Solano E , Figueroa B , Zúñiga P , Laclette JP . Health research funding in Mexico: the need for a long-term agenda. PloS One. 2012; 7: e51195.
   PubMed Web of Science ®Google Scholar
• Bourgeois FT , Murthy S , Pinto C , Olson KL , Ioannidis JPA , Mandl KD . Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics. 2012; 130: 285–92.
   Google Scholar
• World Health Organization. Neglected tropical diseases: the 17 neglected tropical diseases. Available from: http://www.who.int/neglected_diseases/diseases/en/[cited 9 August 2013]..
   Google Scholar
• Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2010 (GBD 2010) data downloads. Available from: http://ghdx.healthmetricsandevaluation.org/global-burden-disease-study-2010-gbd-2010-data-downloads [cited 2 October 2013]..
   Google Scholar
• Moran M , Guzman J , Henderson K , Abela-Oversteegen L , Wu L , Omune B . G-FINDER 2010 –neglected disease research and development: is the global financial crisis changing R&D?. 2011; Sydney: Policy Cures.
   Google Scholar
• Terry RF , Allen L , Gardner C , Guzman J , Moran M , Viergever RF . Mapping global health research investments, time for new thinking – a Babel Fish for research data. Health Res Policy Syst. 2012; 10: 28.
   Google Scholar
• Brower V . The squeaky wheel gets the grease. Research funding is not necessarily allocated to those who need it most. EMBO Rep. 2005; 6: 1014–7.
   Google Scholar
• World Health Organization. Global Burden of Disease (GBD). Available from: http://www.who.int/healthinfo/global_burden_disease/en/index.html [cited 2 October 2013]..
   Google Scholar
• NIH Research Portfolio Online Reporting Tools (RePORT). Estimates of funding for various Research, Condition, and Disease Categories (RCDC). Available from: http://report.nih.gov/categorical_spending.aspx [cited 2 October 2013]..
   Google Scholar
• Nwaka S , Ilunga TB , Da Silva JS , Rial Verde E , Hackley D , De Vré R . Developing ANDI: a novel approach to health product R&D in Africa. PLoS Med. 2010; 7: e1000293. [PubMed Abstract].
   Google Scholar
• Herrera AP , Snipes SA , King DW , Torres-Vigil I , Goldberg DS , Weinberg AD . Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010; 100: S105–12.
   Google Scholar
• Dear RF , Barratt AL , McGeechan K , Askie L , Simes J , Tattersall MHN . Landscape of cancer clinical trials in Australia: using trial registries to guide future research. Med J Aust. 2011; 194: 387–91.
   Google Scholar
• Dear RF , Barratt AL , Evans A , Simes J , Newsom J , Kent D , etal. Identifying and prioritising gaps in colorectal cancer trials research in Australia. Med J Aust. 2012; 197: 507–11.
   Google Scholar
• World Health Organization. Draft Working Paper 2: coordination and priority setting in R&D to meet health needs in developing countries. 2013; Geneva: World Health Organization, Department of Public Health Innovation and Intellectual Property.
   Google Scholar
• Nwaka S , Ridley RG . Virtual drug discovery and development for neglected diseases through public-private partnerships. Nat Rev Drug Discov. 2003; 2: 919–28.
   Google Scholar
• Nundy S , Han E . New technology needs for noncommunicable diseases in developing countries: a landscaping study. 2012; Washington: DC: Results for Development Institute (R4D).
   Google Scholar
• Hay Burgess DC , Wasserman J , Dahl CA . Global health diagnostics. Nature. 2006; 444: 1–2.
   Google Scholar
• Viergever RF , Olifson S , Ghaffar A , Terry RF . A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010; 8: 36.
   Google Scholar
• Viergever RF . Aid alignment for global health research: the role of HIROs. Health Res Policy Syst. 2011; 9: 12. Available from: http://www.alltrials.net/supporters/gsk-statement/ [cited 2 October 2013]..
   Google Scholar
• All Trials campaign: GSK statement. Available from: http://www.alltrials.net/supporters/gsk-statement/ [cited 2 October 2013]..
   Google Scholar
• Moon S . Medicines as global public goods: the governance of technological innovation in the new era of global health. Glob Health Gov. 2009; 2
   Google Scholar
• The Global Ministerial Forum on Research for Health (2008). The Bamako call to action on research for health: strengthening research for health, development, and equity. Bamako, Mali.
   Google Scholar
• Global Forum for Health Research. Monitoring Financial flows for Health Research 2008: prioritizing research for health equity. 2008; Geneva: Global Forum for Health Research.
   Google Scholar
• Global Health Technologies Coalition and Policy Cures. Saving lives and creating impact: why investing in global health research works. 2012; Sydney: GHTC and Policy Cures.
   Google Scholar
• Sridhar D . Who sets the global health research agenda? The challenge of multi-bi financing. PLoS Med. 2012; 9: e1001312.
   Google Scholar
• Without borders. Nature. 2013; 497: 536.
   Web of Science ®Google Scholar
• Collier R . Research allocations: subjective factors often influence outlays. CMAJ. 2010; 182: E387–8.
   Google Scholar
• Olden K , Ramos R . Priority setting in health research: tradeoffs and consequences. Autism Advocate. 2008; 1: 16–24.
   Google Scholar
• NSB/NSF seeks input on proposed merit review criteria revision and principles (NSB-11-42). Available from: http://nsf.gov/nsb/publications/2011/06_mrtf.jsp [cited 1 June 2013]..
   Google Scholar
• Zed Books Ltd. Global health watch 2. An alternative world health report. 2008; London: Zed Books Ltd.
   Google Scholar
• Rudan I , Gibson J , Kapiriri L , Lansang MA , Hyder AA , Lawn J , etal. Setting priorities in global child health research investments: assessment of principles and practice. Croat Med J. 2007; 48: 595–604.
   Google Scholar
• Walport M , Brest P . Sharing research data to improve public health. Lancet. 2011; 377: 537–9.
   Google Scholar
• The Commission on Macroeconomics and Health. Macroeconomics and health: Investing in health for economic development. 2001; Geneva: World Health Organization.
   Google Scholar
• World Health Organization. Draft Working Paper 1: a global health R&D observatory – developing a case for its development. 2013; Geneva: WHO, Department of Public Health Innovation and Intellectual Property.
   Google Scholar
• The European and Developing Countries Clinical Trials Partnership (EDCTP). Available from: http://www.edctp.org/ [cited 9 August 2013]..
   Google Scholar
• ESSENCE on Health Research (Enhancing Support for Strengthening the Effectiveness of National Capacity Efforts). Available from: http://www.who.int/tdr/partnerships/initiatives/essence/en/ [cited 9 August 2013]..
   Google Scholar
• Council on Health Research for Development (COHRED). Our mission. Available from: http://www.cohred.org/our-mission/ [cited 9 September 2013]..
   Google Scholar
• IJsselmuiden C , Kennedy A . Building and strengthening national health research systems: a manager's guide to developing and managing effective health research systems. 2008; Geneva: Council on Health Research for Development (COHRED).
   Google Scholar
• World Health Organization (WHO). Building research systems for universal health coverage. In: The World Health Report 2013: research for universal health coverage. 2013; Geneva: WHO.
   Google Scholar
• News in brief: antibiotic R&D gets a dose of funding. Nat Rev Drug Discov. 2012; 11: 507.
   Google Scholar
• Hirschler B . U.S. government taps GlaxoSmithKline for new antibiotics. 2013. Available from: http://www.reuters.com/article/2013/05/22/us-glaxosmithkline-usa-antibiotics-idUSBRE94L0FG20130522 [cited 2 October 2013]..
   Google Scholar
• Villa S , Compagni A , Reich MR . Orphan drug legislation: lessons for neglected tropical diseases. Int J Health Plann Manage. 2009; 24: 27–42.
   Google Scholar
• Boots I , Sukhai RN , Klein RH , Holl RA , Wit JM , Cohen AF , etal. Stimulation programs for pediatric drug research--do children really benefit?. Eur J Pediatr. 2007; 166: 849–55.
   Google Scholar
• Sridhar D . Health policy: regulate alcohol for global health. Nature. 2012; 482: 302.
   Google Scholar
• World Health Organization. Report by the Secretariat: background document to the open-ended meeting of Member States on the follow-up of the report of the Consultative Expert Working Group on research and development: financing and coordination. Document number A/CEWG/3. 2012; Geneva: WHO, Department of Public Health Innovation and Intellectual Property.
   Google Scholar
• World Health Organization. Draft Working Paper 3: financing mechanisms for health R&D. 2013; Geneva: WHO, Department of Public Health Innovation and Intellectual Property.
   Google Scholar
• Sixty-Sixth World Health Assembly: daily notes on proceedings. 2013. Available from: http://www.who.int/mediacentre/events/2013/wha66/journal/en/index.html[cited 2 October 2013]. Notes of Monday, 27 May.
   Google Scholar
• Report of the open-ended meeting of Member States on the follow-up of the report of the Consultative Expert Working Group on research and development: financing and coordination (CEWG). , 2012; Geneva 26–28. Available from: http://apps.who.int/gb/ebwha/pdf_files/EB132/B132_21-en.pdf [cited 2 October 2013]. November 2012.
   Google Scholar
• Research and development coordination and financing. report of the expert working group. 2010; Geneva Available from: http://www.who.int/phi/documents/RDFinancingwithISBN.pdf [cited 2 October 2013]..
   Google Scholar
• Public health. innovation and intellectual property rights: report of the Commission on Intellectual Property Rights, Innovation and Public Health. 2006; Geneva Available from: http://www.who.int/intellectualproperty/report/en/ [cited 2 October 2013]..
   Google Scholar
• Ad Hoc Committee on Health Research Relating to Future Intervention Options. Investing in health research and development. 1996; Geneva Available from: http://apps.who.int/iris/handle/10665/63024?mode=simple&submit_simple=Show+simple+item+record .
   Google Scholar
• The Advisory Committee on Health Research. A research policy agenda for science and technology to support global health development. 1998; Geneva: World Health Organization.
   Google Scholar
• World Health Organization. Draft Working Paper 4: health R&D demonstration projects – a scoping document. 2013; Geneva: World Health Organization, Department of Public Health Innovation and Intellectual Property.
   Google Scholar
• Murray CJL , Ezzati M , Flaxman AD , Lim S , Lozano R , Michaud C . GBD 2010: design, definitions, and metrics. Lancet. 2012; 380: 2063–6.
   Google Scholar
• World Health Organization. The global burden of disease: 2004 update. 2008; Geneva: WHO.
   Google Scholar
• Health technologies: report by the Secretariat. World Health Organization Executive Board document EB 121/11. 2007. Available from: http://apps.who.int/iris/bitstream/10665/22966/1/B121_11-en.pdf [cited 2 October 2013]..
   Google Scholar
• Moran M , Guzman J , Ropars A-L , Jorgensen M , McDonald A , Potter S . The malaria product pipeline: planning for the future. 2007; Sydney Available from: http://www.policycures.org/downloads/The_malaria_product_pipeline_planning_for_the_future.pdf [cited 2 October 2013]..
   Google Scholar
• Rezaie R , McGahan AM , Daar AS , Singer PA . Innovative drugs and vaccines in China, India and Brazil. Nat Biotechnol. 2012; 30: 923–6.
   Google Scholar
• Global Forum for Health Research. Monitoring financial flows for health research series. 2001; 2009 Geneva: Global Forum for Health Research.
   Google Scholar
• Global Forum for Health Research. The 3D combined approach matrix. an improved tool for settng priorities in research for health. 2009; Geneva: Global Forum for Health Research.
   Google Scholar
• Health technology assessment process. the Canadian Coordinating Office for Health Technology Assesssment. Available from: http://www.cgh.uottawa.ca/whocc/projects/eo_toolkit/hta.htm [cited 2 October 2013]..
   Google Scholar